NVIDIA BioNeMo Framework Accelerates AI Drug Discovery

HIT Consultant November 18, 2024
Fred Pennic

What You Should Know:

– NVIDIA announced widespread adoption of its open-source BioNeMo™ Framework by pharmaceutical companies, techbio innovators, and AI researchers to accelerate drug discovery and molecule design.

– The framework provides a powerful suite of tools for scaling AI models in biomolecular research, bringing supercomputing capabilities to the forefront of drug development.

Accelerating Drug Discovery with AI

The BioNeMo Framework addresses the growing need for specialized tools to handle the complex demands of biomolecular research. By providing a collection of accelerated computing resources, it enables researchers to:

• Scale AI models: Exponentially increase the scale of AI models used in drug discovery.
• Gather insights at scale: Analyze vast datasets and extract meaningful insights more efficiently.
• Design...

Today's Sponsors

Today's Sponsor